Rafael Malgor
Concepts (339)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endovascular Procedures | 25 | 2026 | 384 | 6.920 |
Why?
| | Vascular Surgical Procedures | 22 | 2026 | 339 | 5.000 |
Why?
| | Blood Vessel Prosthesis Implantation | 16 | 2025 | 228 | 3.500 |
Why?
| | Venous Thrombosis | 11 | 2026 | 194 | 3.160 |
Why?
| | Aortic Aneurysm, Abdominal | 10 | 2025 | 167 | 2.820 |
Why?
| | Angioplasty, Balloon | 6 | 2023 | 94 | 2.810 |
Why?
| | Stents | 15 | 2024 | 556 | 2.800 |
Why?
| | Varicose Veins | 6 | 2024 | 16 | 2.280 |
Why?
| | Upper Extremity | 4 | 2026 | 112 | 2.230 |
Why?
| | Vena Cava, Inferior | 7 | 2026 | 81 | 2.170 |
Why?
| | Surgeons | 7 | 2025 | 339 | 1.980 |
Why?
| | Carotid Stenosis | 5 | 2024 | 102 | 1.960 |
Why?
| | Vascular System Injuries | 8 | 2026 | 77 | 1.960 |
Why?
| | Venous Insufficiency | 6 | 2024 | 12 | 1.910 |
Why?
| | Vena Cava Filters | 5 | 2024 | 64 | 1.870 |
Why?
| | Aorta, Thoracic | 8 | 2026 | 286 | 1.820 |
Why?
| | Pulmonary Embolism | 5 | 2024 | 244 | 1.790 |
Why?
| | Wounds, Nonpenetrating | 9 | 2026 | 316 | 1.760 |
Why?
| | Treatment Outcome | 50 | 2026 | 11679 | 1.740 |
Why?
| | Femoral Artery | 4 | 2023 | 190 | 1.720 |
Why?
| | Veins | 5 | 2017 | 68 | 1.650 |
Why?
| | Aortic Aneurysm | 3 | 2022 | 70 | 1.630 |
Why?
| | Thoracic Injuries | 6 | 2026 | 72 | 1.580 |
Why?
| | Peripheral Arterial Disease | 6 | 2023 | 503 | 1.580 |
Why?
| | Blood Vessel Prosthesis | 10 | 2024 | 140 | 1.520 |
Why?
| | Popliteal Artery | 3 | 2023 | 62 | 1.490 |
Why?
| | Ultrasonography, Doppler, Duplex | 9 | 2017 | 40 | 1.450 |
Why?
| | Anticoagulants | 8 | 2026 | 722 | 1.430 |
Why?
| | Ischemia | 7 | 2021 | 421 | 1.410 |
Why?
| | Intermittent Claudication | 3 | 2021 | 121 | 1.390 |
Why?
| | Venous Thromboembolism | 6 | 2022 | 324 | 1.380 |
Why?
| | Laser Therapy | 4 | 2022 | 135 | 1.230 |
Why?
| | Saphenous Vein | 5 | 2022 | 37 | 1.170 |
Why?
| | Vascular Patency | 11 | 2026 | 121 | 1.160 |
Why?
| | Endarterectomy, Carotid | 2 | 2024 | 60 | 1.110 |
Why?
| | Aorta, Abdominal | 2 | 2025 | 52 | 1.060 |
Why?
| | Lower Extremity | 6 | 2025 | 438 | 1.040 |
Why?
| | Upper Extremity Deep Vein Thrombosis | 1 | 2026 | 3 | 0.960 |
Why?
| | Catheter Ablation | 3 | 2022 | 353 | 0.940 |
Why?
| | Matrix Metalloproteinase Inhibitors | 1 | 2025 | 18 | 0.930 |
Why?
| | Risk Factors | 26 | 2026 | 10779 | 0.920 |
Why?
| | Doxycycline | 1 | 2025 | 62 | 0.910 |
Why?
| | Thrombectomy | 1 | 2026 | 78 | 0.900 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2025 | 132 | 0.890 |
Why?
| | Arteriovenous Shunt, Surgical | 2 | 2017 | 19 | 0.880 |
Why?
| | Atherectomy | 2 | 2023 | 37 | 0.870 |
Why?
| | Humans | 96 | 2026 | 144759 | 0.870 |
Why?
| | Iliac Aneurysm | 2 | 2022 | 19 | 0.870 |
Why?
| | Prosthesis Design | 10 | 2024 | 357 | 0.870 |
Why?
| | Fibrinolytic Agents | 3 | 2020 | 291 | 0.850 |
Why?
| | Time Factors | 24 | 2026 | 7173 | 0.840 |
Why?
| | Inflammation Mediators | 2 | 2025 | 509 | 0.820 |
Why?
| | Health Care Costs | 2 | 2025 | 427 | 0.800 |
Why?
| | Cranial Nerve Injuries | 1 | 2023 | 5 | 0.780 |
Why?
| | Carotid Body Tumor | 1 | 2023 | 5 | 0.780 |
Why?
| | Aged | 35 | 2026 | 25913 | 0.760 |
Why?
| | Mesenteric Vascular Occlusion | 3 | 2011 | 5 | 0.760 |
Why?
| | Aged, 80 and over | 18 | 2024 | 8265 | 0.760 |
Why?
| | Embolic Protection Devices | 1 | 2022 | 12 | 0.750 |
Why?
| | Vascular Diseases | 3 | 2015 | 251 | 0.730 |
Why?
| | Aortic Aneurysm, Thoracic | 3 | 2024 | 139 | 0.720 |
Why?
| | Anti-Inflammatory Agents | 1 | 2025 | 474 | 0.710 |
Why?
| | Intestinal Perforation | 2 | 2012 | 44 | 0.710 |
Why?
| | Duodenum | 2 | 2012 | 77 | 0.700 |
Why?
| | Practice Patterns, Physicians' | 4 | 2020 | 1356 | 0.690 |
Why?
| | Coated Materials, Biocompatible | 1 | 2021 | 65 | 0.670 |
Why?
| | Vascular Calcification | 2 | 2020 | 110 | 0.660 |
Why?
| | Renal Dialysis | 2 | 2017 | 462 | 0.660 |
Why?
| | Angioplasty | 3 | 2012 | 50 | 0.650 |
Why?
| | Retrospective Studies | 21 | 2026 | 17066 | 0.640 |
Why?
| | Platelet Aggregation Inhibitors | 2 | 2021 | 497 | 0.640 |
Why?
| | Male | 46 | 2026 | 72315 | 0.620 |
Why?
| | Lithotripsy | 1 | 2020 | 49 | 0.620 |
Why?
| | Middle Aged | 34 | 2026 | 35875 | 0.620 |
Why?
| | Female | 52 | 2026 | 78271 | 0.610 |
Why?
| | Leg | 3 | 2021 | 239 | 0.610 |
Why?
| | Plaque, Atherosclerotic | 1 | 2020 | 60 | 0.610 |
Why?
| | Benchmarking | 1 | 2021 | 188 | 0.600 |
Why?
| | Aorta | 2 | 2012 | 429 | 0.600 |
Why?
| | Risk Adjustment | 1 | 2019 | 85 | 0.590 |
Why?
| | Watchful Waiting | 1 | 2019 | 89 | 0.580 |
Why?
| | Postoperative Complications | 12 | 2025 | 2919 | 0.550 |
Why?
| | Iliac Artery | 2 | 2022 | 55 | 0.530 |
Why?
| | Prosthesis Failure | 3 | 2019 | 127 | 0.520 |
Why?
| | Atherosclerosis | 1 | 2021 | 409 | 0.520 |
Why?
| | Surgical Stapling | 1 | 2017 | 16 | 0.510 |
Why?
| | Vascular Malformations | 2 | 2015 | 50 | 0.510 |
Why?
| | Aneurysm | 1 | 2017 | 37 | 0.500 |
Why?
| | Thoracoscopy | 1 | 2017 | 62 | 0.500 |
Why?
| | Sclerotherapy | 3 | 2024 | 19 | 0.490 |
Why?
| | Medicare | 1 | 2022 | 886 | 0.480 |
Why?
| | Brachial Artery | 1 | 2017 | 206 | 0.460 |
Why?
| | Hand | 1 | 2017 | 161 | 0.460 |
Why?
| | Peripheral Vascular Diseases | 2 | 2013 | 104 | 0.450 |
Why?
| | Klippel-Trenaunay-Weber Syndrome | 1 | 2015 | 3 | 0.450 |
Why?
| | Pneumonectomy | 1 | 2017 | 169 | 0.450 |
Why?
| | Risk Assessment | 10 | 2025 | 3671 | 0.440 |
Why?
| | Subclavian Artery | 1 | 2014 | 28 | 0.420 |
Why?
| | Perception | 1 | 2017 | 377 | 0.410 |
Why?
| | Tissue and Organ Harvesting | 1 | 2014 | 73 | 0.410 |
Why?
| | Catheterization | 2 | 2012 | 183 | 0.410 |
Why?
| | Arterial Occlusive Diseases | 1 | 2014 | 90 | 0.400 |
Why?
| | Registries | 6 | 2025 | 2385 | 0.400 |
Why?
| | Infarction | 1 | 2013 | 9 | 0.400 |
Why?
| | Endarterectomy | 2 | 2012 | 5 | 0.400 |
Why?
| | Cardiovascular Agents | 1 | 2015 | 164 | 0.390 |
Why?
| | Renal Artery | 1 | 2013 | 43 | 0.390 |
Why?
| | Brachiocephalic Trunk | 1 | 2012 | 11 | 0.390 |
Why?
| | Intraoperative Complications | 1 | 2014 | 155 | 0.380 |
Why?
| | Catheter Obstruction | 1 | 2012 | 4 | 0.380 |
Why?
| | Phlebography | 5 | 2021 | 39 | 0.380 |
Why?
| | Device Removal | 4 | 2024 | 143 | 0.370 |
Why?
| | Adult | 24 | 2026 | 40449 | 0.370 |
Why?
| | Vascular Access Devices | 1 | 2012 | 30 | 0.370 |
Why?
| | Mechanical Thrombolysis | 1 | 2012 | 5 | 0.370 |
Why?
| | Ureteral Diseases | 1 | 2012 | 4 | 0.360 |
Why?
| | Urinary Fistula | 1 | 2012 | 9 | 0.360 |
Why?
| | Catheters, Indwelling | 1 | 2012 | 96 | 0.360 |
Why?
| | Fibrin Tissue Adhesive | 1 | 2012 | 20 | 0.360 |
Why?
| | Health Services Accessibility | 1 | 2020 | 1098 | 0.360 |
Why?
| | Time-to-Treatment | 3 | 2026 | 243 | 0.350 |
Why?
| | Vascular Fistula | 1 | 2012 | 22 | 0.350 |
Why?
| | Endoscopy | 1 | 2014 | 316 | 0.350 |
Why?
| | Aneurysm, False | 1 | 2012 | 45 | 0.350 |
Why?
| | Lung Neoplasms | 2 | 2017 | 2637 | 0.340 |
Why?
| | Thrombin | 1 | 2012 | 166 | 0.330 |
Why?
| | Elective Surgical Procedures | 2 | 2024 | 201 | 0.330 |
Why?
| | Thrombolytic Therapy | 1 | 2012 | 163 | 0.330 |
Why?
| | Catheterization, Central Venous | 1 | 2012 | 122 | 0.330 |
Why?
| | Surgical Wound Infection | 2 | 2024 | 316 | 0.320 |
Why?
| | Foreign-Body Migration | 1 | 2010 | 32 | 0.320 |
Why?
| | Exercise Therapy | 1 | 2015 | 473 | 0.310 |
Why?
| | Celiac Artery | 2 | 2025 | 20 | 0.310 |
Why?
| | Length of Stay | 4 | 2024 | 1337 | 0.310 |
Why?
| | Tomography, X-Ray Computed | 7 | 2014 | 2730 | 0.310 |
Why?
| | Limb Salvage | 4 | 2025 | 70 | 0.300 |
Why?
| | Hospital Mortality | 4 | 2024 | 1030 | 0.290 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2017 | 1414 | 0.290 |
Why?
| | New York | 3 | 2014 | 125 | 0.290 |
Why?
| | Evidence-Based Medicine | 5 | 2026 | 732 | 0.280 |
Why?
| | Aortography | 3 | 2014 | 52 | 0.280 |
Why?
| | Cost-Benefit Analysis | 2 | 2025 | 634 | 0.270 |
Why?
| | Regional Blood Flow | 3 | 2017 | 514 | 0.270 |
Why?
| | Constriction, Pathologic | 3 | 2013 | 248 | 0.260 |
Why?
| | Sternum | 2 | 2024 | 26 | 0.260 |
Why?
| | Reoperation | 5 | 2019 | 630 | 0.260 |
Why?
| | Health Care Surveys | 2 | 2020 | 539 | 0.260 |
Why?
| | Sternotomy | 2 | 2024 | 23 | 0.250 |
Why?
| | Endoleak | 2 | 2019 | 17 | 0.240 |
Why?
| | Retroperitoneal Neoplasms | 1 | 2026 | 28 | 0.240 |
Why?
| | Internship and Residency | 3 | 2021 | 1257 | 0.240 |
Why?
| | Aortic Rupture | 2 | 2020 | 28 | 0.230 |
Why?
| | Median Arcuate Ligament Syndrome | 1 | 2025 | 8 | 0.230 |
Why?
| | Ulcer | 1 | 2025 | 37 | 0.230 |
Why?
| | Hematoma | 1 | 2025 | 59 | 0.230 |
Why?
| | Kidney | 1 | 2013 | 1495 | 0.230 |
Why?
| | Injury Severity Score | 3 | 2021 | 600 | 0.220 |
Why?
| | Sclerosing Solutions | 1 | 2024 | 10 | 0.220 |
Why?
| | Kaplan-Meier Estimate | 3 | 2012 | 965 | 0.220 |
Why?
| | Implant Capsular Contracture | 1 | 2024 | 4 | 0.220 |
Why?
| | Renal Nutcracker Syndrome | 1 | 2024 | 8 | 0.220 |
Why?
| | Breast Implantation | 1 | 2024 | 16 | 0.210 |
Why?
| | Breast Implants | 1 | 2024 | 25 | 0.210 |
Why?
| | Hematuria | 1 | 2024 | 11 | 0.210 |
Why?
| | Aortic Diseases | 1 | 2025 | 124 | 0.210 |
Why?
| | Urologic Diseases | 1 | 2024 | 40 | 0.210 |
Why?
| | Stockings, Compression | 2 | 2015 | 5 | 0.200 |
Why?
| | Young Adult | 8 | 2025 | 14105 | 0.200 |
Why?
| | Negative-Pressure Wound Therapy | 1 | 2023 | 28 | 0.200 |
Why?
| | Sarcoma | 1 | 2026 | 205 | 0.200 |
Why?
| | Carcinoma, Renal Cell | 1 | 2026 | 234 | 0.200 |
Why?
| | Predictive Value of Tests | 5 | 2024 | 2115 | 0.200 |
Why?
| | Accidents, Traffic | 2 | 2015 | 190 | 0.200 |
Why?
| | C-Reactive Protein | 1 | 2025 | 416 | 0.200 |
Why?
| | Down-Regulation | 1 | 2025 | 627 | 0.190 |
Why?
| | Patient Selection | 3 | 2026 | 719 | 0.190 |
Why?
| | Neoplasms | 3 | 2025 | 2875 | 0.190 |
Why?
| | Intracranial Embolism | 1 | 2022 | 34 | 0.190 |
Why?
| | Robotic Surgical Procedures | 1 | 2025 | 182 | 0.190 |
Why?
| | Surgical Flaps | 1 | 2024 | 142 | 0.190 |
Why?
| | Databases, Factual | 3 | 2024 | 1486 | 0.180 |
Why?
| | Multiple Trauma | 2 | 2021 | 116 | 0.180 |
Why?
| | Health Status Disparities | 1 | 2025 | 321 | 0.180 |
Why?
| | Lymphedema | 1 | 2022 | 24 | 0.180 |
Why?
| | Acute Disease | 4 | 2025 | 1030 | 0.180 |
Why?
| | Administration, Oral | 2 | 2021 | 847 | 0.180 |
Why?
| | Angiography | 2 | 2013 | 208 | 0.180 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2008 | 1720 | 0.180 |
Why?
| | Off-Label Use | 1 | 2022 | 49 | 0.180 |
Why?
| | Morbidity | 1 | 2023 | 323 | 0.180 |
Why?
| | Surveys and Questionnaires | 7 | 2022 | 6048 | 0.180 |
Why?
| | Kidney Neoplasms | 1 | 2026 | 412 | 0.170 |
Why?
| | Follow-Up Studies | 4 | 2021 | 5408 | 0.170 |
Why?
| | Varicose Ulcer | 1 | 2021 | 5 | 0.170 |
Why?
| | Consensus | 4 | 2026 | 488 | 0.170 |
Why?
| | Neurosurgery | 1 | 2021 | 41 | 0.170 |
Why?
| | Mesenteric Arteries | 2 | 2011 | 18 | 0.170 |
Why?
| | Prognosis | 4 | 2015 | 4282 | 0.170 |
Why?
| | Iliac Vein | 1 | 2021 | 15 | 0.170 |
Why?
| | Incidence | 4 | 2021 | 2879 | 0.170 |
Why?
| | Abdominal Pain | 2 | 2012 | 146 | 0.160 |
Why?
| | Prospective Studies | 6 | 2021 | 7990 | 0.160 |
Why?
| | Catheters | 1 | 2021 | 75 | 0.160 |
Why?
| | Global Health | 2 | 2020 | 401 | 0.160 |
Why?
| | Efficiency | 1 | 2021 | 103 | 0.160 |
Why?
| | Brazil | 1 | 2020 | 180 | 0.160 |
Why?
| | Ultrasonography, Interventional | 2 | 2012 | 160 | 0.160 |
Why?
| | Puerperal Disorders | 1 | 2020 | 37 | 0.160 |
Why?
| | Pandemics | 4 | 2020 | 1694 | 0.150 |
Why?
| | Certification | 1 | 2021 | 119 | 0.150 |
Why?
| | Patient Care Team | 1 | 2025 | 689 | 0.150 |
Why?
| | Arteriovenous Fistula | 1 | 2020 | 38 | 0.150 |
Why?
| | Pregnancy Complications, Cardiovascular | 1 | 2020 | 83 | 0.150 |
Why?
| | Chronic Disease | 5 | 2024 | 1813 | 0.150 |
Why?
| | Catheterization, Peripheral | 1 | 2021 | 118 | 0.150 |
Why?
| | Patient Acuity | 1 | 2019 | 47 | 0.150 |
Why?
| | Recurrence | 3 | 2012 | 1135 | 0.150 |
Why?
| | Education, Medical, Graduate | 2 | 2021 | 557 | 0.150 |
Why?
| | Cardiology | 1 | 2022 | 353 | 0.140 |
Why?
| | General Surgery | 1 | 2021 | 207 | 0.140 |
Why?
| | Delphi Technique | 3 | 2025 | 329 | 0.140 |
Why?
| | United States | 8 | 2024 | 15966 | 0.130 |
Why?
| | Clinical Decision-Making | 2 | 2021 | 359 | 0.130 |
Why?
| | Educational Measurement | 1 | 2021 | 326 | 0.130 |
Why?
| | Disease Progression | 1 | 2025 | 2847 | 0.130 |
Why?
| | Disease Management | 1 | 2021 | 645 | 0.130 |
Why?
| | Ligation | 1 | 2017 | 92 | 0.130 |
Why?
| | Thrombosis | 1 | 2020 | 393 | 0.120 |
Why?
| | Clinical Competence | 3 | 2021 | 1244 | 0.120 |
Why?
| | Postoperative Hemorrhage | 1 | 2017 | 104 | 0.120 |
Why?
| | Brain Injuries, Traumatic | 1 | 2021 | 441 | 0.110 |
Why?
| | Stroke | 1 | 2024 | 1256 | 0.110 |
Why?
| | Motorcycles | 1 | 2014 | 7 | 0.110 |
Why?
| | Obesity, Morbid | 1 | 2019 | 281 | 0.110 |
Why?
| | Ankle Brachial Index | 1 | 2015 | 41 | 0.110 |
Why?
| | Adaptation, Psychological | 1 | 2020 | 717 | 0.110 |
Why?
| | Pedestrians | 1 | 2014 | 9 | 0.110 |
Why?
| | Cross-Sectional Studies | 3 | 2020 | 5868 | 0.110 |
Why?
| | Severity of Illness Index | 2 | 2013 | 2925 | 0.100 |
Why?
| | Biomarkers | 1 | 2025 | 4271 | 0.100 |
Why?
| | Multidetector Computed Tomography | 1 | 2013 | 40 | 0.100 |
Why?
| | Minnesota | 1 | 2013 | 169 | 0.100 |
Why?
| | Exercise Tolerance | 1 | 2015 | 283 | 0.090 |
Why?
| | Ovary | 1 | 2014 | 228 | 0.090 |
Why?
| | Duodenoscopy | 1 | 2012 | 8 | 0.090 |
Why?
| | Gastroscopy | 1 | 2012 | 18 | 0.090 |
Why?
| | Matrix Metalloproteinases | 1 | 2013 | 98 | 0.090 |
Why?
| | MEDLINE | 1 | 2012 | 20 | 0.090 |
Why?
| | Injections, Intralesional | 1 | 2012 | 36 | 0.090 |
Why?
| | Ultrasonography, Doppler, Color | 1 | 2012 | 37 | 0.090 |
Why?
| | Cystoscopy | 1 | 2012 | 21 | 0.090 |
Why?
| | Debridement | 1 | 2012 | 86 | 0.090 |
Why?
| | Stress, Psychological | 1 | 2020 | 1152 | 0.090 |
Why?
| | Combined Modality Therapy | 1 | 2015 | 1266 | 0.090 |
Why?
| | Carotid Artery, Common | 1 | 2011 | 31 | 0.090 |
Why?
| | Hospitalization | 1 | 2022 | 2433 | 0.090 |
Why?
| | Echinococcosis | 1 | 2011 | 5 | 0.090 |
Why?
| | Fibrinolysis | 1 | 2013 | 162 | 0.090 |
Why?
| | Pilot Projects | 1 | 2017 | 1886 | 0.080 |
Why?
| | Mesenteric Ischemia | 1 | 2010 | 2 | 0.080 |
Why?
| | Statistics, Nonparametric | 1 | 2012 | 427 | 0.080 |
Why?
| | Warfarin | 1 | 2022 | 170 | 0.080 |
Why?
| | Recovery of Function | 1 | 2015 | 707 | 0.080 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 2011 | 136 | 0.080 |
Why?
| | Coronary Artery Bypass | 1 | 2012 | 268 | 0.080 |
Why?
| | Dog Diseases | 1 | 2011 | 70 | 0.080 |
Why?
| | Embolization, Therapeutic | 1 | 2012 | 242 | 0.080 |
Why?
| | Linear Models | 1 | 2012 | 854 | 0.080 |
Why?
| | Walking | 1 | 2015 | 545 | 0.080 |
Why?
| | Glomerular Filtration Rate | 1 | 2013 | 760 | 0.080 |
Why?
| | Chi-Square Distribution | 1 | 2010 | 529 | 0.080 |
Why?
| | Comparative Effectiveness Research | 1 | 2010 | 170 | 0.070 |
Why?
| | Adolescent | 4 | 2025 | 22428 | 0.070 |
Why?
| | Secondary Prevention | 1 | 2011 | 254 | 0.070 |
Why?
| | Mesentery | 1 | 2009 | 45 | 0.070 |
Why?
| | Animals | 3 | 2025 | 38058 | 0.070 |
Why?
| | Attitude of Health Personnel | 1 | 2017 | 1185 | 0.070 |
Why?
| | Radiography, Interventional | 1 | 2010 | 130 | 0.070 |
Why?
| | Multivariate Analysis | 1 | 2012 | 1539 | 0.070 |
Why?
| | Recombinant Proteins | 1 | 2012 | 1370 | 0.070 |
Why?
| | Child | 3 | 2021 | 22633 | 0.060 |
Why?
| | Logistic Models | 1 | 2012 | 2117 | 0.060 |
Why?
| | Age Factors | 1 | 2014 | 3333 | 0.060 |
Why?
| | Proportional Hazards Models | 1 | 2010 | 1325 | 0.060 |
Why?
| | Survival Rate | 1 | 2012 | 2089 | 0.060 |
Why?
| | Hemorrhage | 1 | 2022 | 809 | 0.060 |
Why?
| | Cardiac Surgical Procedures | 1 | 2012 | 609 | 0.060 |
Why?
| | Coronary Artery Disease | 1 | 2012 | 741 | 0.060 |
Why?
| | Hemodynamics | 2 | 2021 | 1121 | 0.060 |
Why?
| | Operative Time | 1 | 2025 | 175 | 0.050 |
Why?
| | Silicone Gels | 1 | 2024 | 4 | 0.050 |
Why?
| | Renal Veins | 1 | 2024 | 18 | 0.050 |
Why?
| | Pectoralis Muscles | 1 | 2024 | 17 | 0.050 |
Why?
| | Surgical Wound Dehiscence | 1 | 2023 | 19 | 0.050 |
Why?
| | Neoplasm Invasiveness | 1 | 2025 | 508 | 0.050 |
Why?
| | Mammaplasty | 1 | 2024 | 104 | 0.050 |
Why?
| | Quality of Life | 1 | 2015 | 3185 | 0.050 |
Why?
| | Research Design | 1 | 2008 | 1135 | 0.050 |
Why?
| | Test Taking Skills | 1 | 2021 | 5 | 0.040 |
Why?
| | Plastics | 1 | 2021 | 47 | 0.040 |
Why?
| | Cohort Studies | 1 | 2012 | 5960 | 0.040 |
Why?
| | Administration, Topical | 1 | 2021 | 150 | 0.040 |
Why?
| | Verbal Behavior | 1 | 2021 | 43 | 0.040 |
Why?
| | Wound Healing | 1 | 2023 | 351 | 0.040 |
Why?
| | Personal Protective Equipment | 1 | 2020 | 57 | 0.040 |
Why?
| | Specialties, Surgical | 1 | 2020 | 82 | 0.040 |
Why?
| | Sex Factors | 1 | 2025 | 2112 | 0.040 |
Why?
| | Factor Xa Inhibitors | 1 | 2021 | 187 | 0.040 |
Why?
| | Signal Transduction | 1 | 2013 | 5226 | 0.040 |
Why?
| | Bayes Theorem | 1 | 2021 | 433 | 0.040 |
Why?
| | Educational Status | 1 | 2021 | 467 | 0.040 |
Why?
| | Workload | 1 | 2020 | 170 | 0.040 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2020 | 541 | 0.040 |
Why?
| | Salvage Therapy | 1 | 2019 | 162 | 0.030 |
Why?
| | Treatment Failure | 1 | 2019 | 365 | 0.030 |
Why?
| | Hot Temperature | 1 | 2020 | 407 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2021 | 1095 | 0.030 |
Why?
| | Ankle | 1 | 2015 | 63 | 0.030 |
Why?
| | Pressure | 1 | 2015 | 225 | 0.030 |
Why?
| | Asymptomatic Diseases | 1 | 2015 | 102 | 0.030 |
Why?
| | Materials Testing | 1 | 2015 | 354 | 0.030 |
Why?
| | Comorbidity | 1 | 2019 | 1658 | 0.030 |
Why?
| | Sclerosis | 1 | 2013 | 11 | 0.020 |
Why?
| | Wound Infection | 1 | 2012 | 56 | 0.020 |
Why?
| | Antigens, Helminth | 1 | 2011 | 16 | 0.020 |
Why?
| | Sheep Diseases | 1 | 2011 | 9 | 0.020 |
Why?
| | Anthelmintics | 1 | 2011 | 12 | 0.020 |
Why?
| | Italy | 1 | 2011 | 113 | 0.020 |
Why?
| | Rabbits | 1 | 2011 | 648 | 0.020 |
Why?
| | Spinal Cord Ischemia | 1 | 2010 | 60 | 0.020 |
Why?
| | Dogs | 1 | 2011 | 437 | 0.020 |
Why?
| | Magnetic Resonance Angiography | 1 | 2011 | 251 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 851 | 0.020 |
Why?
| | Data Collection | 1 | 2011 | 633 | 0.020 |
Why?
| | Sheep | 1 | 2011 | 880 | 0.020 |
Why?
| | Feces | 1 | 2011 | 513 | 0.020 |
Why?
| | Pregnancy | 1 | 2020 | 7190 | 0.020 |
Why?
| | Prevalence | 1 | 2013 | 2834 | 0.010 |
Why?
| | Kidney Failure, Chronic | 1 | 2010 | 598 | 0.010 |
Why?
|
|
Malgor's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|